United Kingdom (UK) Premenstrual Syndrome Treatment Market (2025-2031) | Growth, Size & Revenue, Segmentation, Trends, Industry, Competitive Landscape, Share, Outlook, Forecast, Companies, Value, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Premenstrual Syndrome Treatment Market - Industry Life Cycle

3.4 United Kingdom (UK) Premenstrual Syndrome Treatment Market - Porter's Five Forces

3.5 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness among women about premenstrual syndrome (PMS) and available treatment options

4.2.2 Growing demand for non-pharmacological treatments for managing PMS symptoms

4.2.3 Technological advancements leading to the development of innovative treatment options

4.3 Market Restraints

4.3.1 Limited reimbursement options for PMS treatments in the UK healthcare system

4.3.2 Side effects associated with traditional pharmacological treatments for PMS

4.3.3 Stigma and taboo surrounding menstrual health impacting the acceptance and adoption of treatments

6.1 United Kingdom (UK) Premenstrual Syndrome Treatment Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Antidepressants, 2021- 2031F

6.1.4 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Diuretics, 2021- 2031F

6.1.5 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Pain Relievers, 2021- 2031F

6.1.6 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Oral Contraceptives & Ovarian Suppression Agents, 2021- 2031F

6.1.7 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market, By Distribution Channel

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.2.3 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By E-commerce, 2021- 2031F

6.2.4 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) Premenstrual Syndrome Treatment Market Export to Major Countries

7.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Imports from Major Countries

8.1 Number of healthcare providers offering non-pharmacological PMS treatment options

8.2 Percentage of women seeking professional help for managing PMS symptoms

8.3 Adoption rate of innovative PMS treatment technologies in the UK market

9.1 United Kingdom (UK) Premenstrual Syndrome Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 United Kingdom (UK) Premenstrual Syndrome Treatment Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Premenstrual Syndrome Treatment Market Competitive Benchmarking, By Operating and Technical Parameters